PROCYSBI(R) to Receive New Treatment Award From Lysosomal Disease Network at the 11th Annual WORLD Symposium
February 10, 2015 09:51 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., Feb. 10, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that the Lysosomal Disease Network (LDN) will present Raptor Pharmaceutical with the 2015...
Raptor Pharmaceutical Appoints Krishna Polu, M.D. as Chief Medical Officer and Michael Smith as Chief Financial Officer
January 07, 2015 08:00 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., Jan. 7, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced the appointment of Krishna R. Polu, M.D., as its Chief Medical Officer and Michael P. Smith...
Raptor Pharmaceutical Appoints Gregg Lapointe and Georges Gemayel to Board of Directors
December 18, 2014 07:30 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., Dec. 18, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced the appointment of Gregg Lapointe and Georges Gemayel, Ph.D. to its Board of Directors,...
Raptor Pharmaceutical to Hold Third Quarter 2014 Financial Results Conference Call and Webcast on Thursday, November 6, at 4:30 p.m. ET
October 29, 2014 16:05 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., Oct. 29, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that the company will release third quarter 2014 financial results on Thursday, November 6,...
Raptor Pharmaceutical Announces Management Changes
October 23, 2014 07:30 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., Oct. 23, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that it has strengthened its leadership team with the hiring of two new executives: David...
Raptor Pharmaceutical to Present at Leerink Rare Disease Roundtable
September 23, 2014 08:00 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., Sept. 23, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that company management will present at the Leerink Rare Disease Roundtable in New York on...
Raptor Receives Orphan Drug Designation for Cysteamine Bitartrate in Huntington's Disease From the European Commission
August 04, 2014 07:30 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., Aug. 4, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that the European Commission (EC) approved its application for orphan drug designation of...
Raptor Pharmaceutical to Participate in Three Upcoming Investor Conferences in June
June 10, 2014 08:00 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., June 10, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that company management will participate in three upcoming investor conferences in...
Raptor Pharmaceutical Reports First Quarter 2014 Financial Results and Provides Corporate Update
May 08, 2014 16:05 ET
|
Raptor Pharmaceutical Inc
Reports PROCYSBI® net product sales of $12.1 million in first quarter 2014 and launch of PROCYSBI® in Germany
Company to host conference call and webcast today at 4:30 p.m. EDT...
Raptor Pharmaceutical to Hold First Quarter 2014 Financial Results Webcast and Conference Call
April 30, 2014 16:05 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., April 30, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that it will release first quarter 2014 financial results after market close on Thursday,...